Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
7,358
Total Claims
$660K
Drug Cost
572
Beneficiaries
$1,153
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-65%
Opioid rate vs peers
0.8% vs 2.2% avg
-18%
Cost per patient vs peers
$1,153 vs $1,411 avg
-13%
Brand preference vs peers
9.3% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
0.8%
Opioid Rate
58
Opioid Claims
$806
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 674 claims · $513K
Generic: 6,575 claims · $143K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dapagliflozin Propanediol | 41 | $59K |
| Semaglutide | 35 | $43K |
| Sitagliptin Phosphate | 28 | $43K |
| Apixaban | 35 | $42K |
| Sitagliptin Phos/Metformin Hcl | 28 | $30K |
| Empagliflozin | 15 | $20K |
| Rivaroxaban | 17 | $19K |
| Icosapent Ethyl | 21 | $19K |
| Budesonide/Glycopyr/Formoterol | 27 | $17K |
| Insulin Glargine,hum.Rec.Anlog | 14 | $15K |
| Diclofenac Sodium | 43 | $8,991 |
| Atorvastatin Calcium | 797 | $8,732 |
| Icosapent Ethyl | 13 | $7,913 |
| Insulin Aspart | 12 | $7,242 |
| Rosuvastatin Calcium | 312 | $5,259 |
Prescribing Profile
Patient Profile
71
Avg Age
57%
Female
0.76
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About